Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-034428

EVP, Head of R&D sold 5,184 shares at $14.55 ($75,427)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dupont Jakob EVP, Head of R&D 2021-05-18 Sale −5,184 $14.55 $75,427 94,945 D: show line 1 in the form
Open-market sales · 5,184 sh · avg $14.55 · $75,427
Loading xslF345X03/doc4.xml…